Bicycle Therapeutics plc Total Liabilities

Latest as of June 2026: €96.32 Million EUR ≈ $112.61 Million USD

Bicycle Therapeutics plc total liabilities. Based on the latest financial reports, Bicycle Therapeutics plc (50BA) has total liabilities worth €96.32 Million EUR (≈ $112.61 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 50BA defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Bicycle Therapeutics plc (2018–2025)

Total liabilities of Bicycle Therapeutics plc from 2018 to 2025. This chart illustrates how Bicycle Therapeutics plc's total liabilities have evolved over time, based on quarterly financial data.

Bicycle Therapeutics plc Competitors by Total Liabilities

The table below lists competitors of Bicycle Therapeutics plc ranked by their total liabilities.

Company	Country	Total Liabilities
Lithium Royalty Corp TO:LIRC	Canada	CA$2.82 Million
Zhejiang Lianxiang Smart Home SHG:603272	China	CN¥100.77 Million
EIH Associated Hotels Limited NSE:EIHAHOTELS	India	Rs1.17 Billion
Goodluck India Limited NSE:GOODLUCK	India	Rs15.18 Billion
Bicycle Therapeutics Ltd NASDAQ:BCYC	USA	$96.32 Million
Sunjuice Holdings Co Ltd TW:1256	Taiwan	NT$1.17 Billion
SillaJen Inc KQ:215600	Korea	₩6.58 Billion
Iones Co. Ltd KQ:114810	Korea	₩36.75 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Bicycle Therapeutics plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 50BA total assets.

Liquidity & Leverage Metrics

Bicycle Therapeutics plc Total Liabilities Ratios Explained

Bicycle Therapeutics plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	12.08	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bicycle Therapeutics plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bicycle Therapeutics plc (2018–2025)

The table below shows the annual total liabilities of Bicycle Therapeutics plc from 2018 to 2025.

Year	Total Liabilities	Change
2025-12-31	€107.62 Million ≈ $125.82 Million	-34.30%
2024-12-31	€163.81 Million ≈ $191.51 Million	-27.01%
2023-12-31	€224.41 Million ≈ $262.36 Million	+60.49%
2022-12-31	€139.83 Million ≈ $163.47 Million	+4.71%
2021-12-31	€133.54 Million ≈ $156.12 Million	+103.28%
2020-12-31	€65.69 Million ≈ $76.80 Million	+286.51%
2019-12-31	€17.00 Million ≈ $19.87 Million	-88.78%
2018-12-31	€151.45 Million ≈ $177.06 Million	--

About Bicycle Therapeutics plc

F:50BA Germany Biotechnology

Market Cap

$184.92 Million

€158.17 Million EUR

Market Cap Rank

#16620 Global

#1576 in Germany

Share Price

€3.14

Change (1 day)

-1.26%

52-Week Range

€3.02 - €6.20

All Time High

€52.00